Evaluating the Risk-Benefit Profile of Corticosteroid Therapy for COVID-19 Patients: A Scoping Review.

Daniel Hsiang-Te Tsai Emma Harmon Jan Goelen Heather E BarryLi-Yang ChenYingfen Hsia

Published in: Pharmacy (Basel, Switzerland) (2024)

Corticosteroids have proven to be an effective treatment for COVID-19 patients in critical condition. However, comparative effectiveness studies should be conducted to assess the efficacy and safety of optimal corticosteroid treatment at the population level. Moreover, the global burden of long COVID is significant, affecting millions with persistent symptoms and long-term health complications. Thus, it is also necessary to evaluate the optimal steroid regimen for long COVID treatment.

Keyphrases

sars cov
coronavirus disease
public health
risk factors
mental health
depressive symptoms
climate change
smoking cessation